LONDON (AP) — Pharmaceutical company AstraZeneca PLC says its schizophrenia drug Seroquel XR has been recommended by European regulators as an add-on treatment for depression. Friday's decision from the European Medicines Agency overturns an earlier rejection for the drug's new use from the Netherlands, which was acting as a reference state for the EU. It is also in line with approval granted by the U.S. Food and Drug Administration in December.
via sun-sentinel.com
No comments:
Post a Comment